MGMT and neoplasm: There were no significant differences between the 2 groups in age, sex, KPS before the start of adjuvant TMZ, enhanced tumor volume, extent of tumor resection, integrated diagnosis by WHO 2021 classification, degree of MGMT promoter methylation, and type of caregiver (all P > .05).